
Outcomes of Down- Titration in Patients with Severe Alopecia Areata Treated with Baricitinib: An Update Through Week 152 from BRAVE-AA2
This trial was presented at the 33rd EADV Congress at Amsterdam by Drs Brett King et al from Yale School of Medicine, New Haven, CT,